| Code | Description | Claims | Beneficiaries | Total Paid |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
264,410 |
222,193 |
$58.07M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
155,024 |
141,958 |
$41.09M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
61,743 |
56,961 |
$16.19M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
35,329 |
31,917 |
$8.39M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
34,135 |
32,647 |
$6.54M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
2,399 |
2,251 |
$6.47M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,234 |
6,761 |
$6.02M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15,238 |
13,364 |
$5.03M |
| G0378 |
Hospital observation service, per hour |
19,758 |
11,677 |
$4.92M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,475 |
11,874 |
$4.34M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,134 |
12,540 |
$3.49M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17,601 |
16,491 |
$3.39M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17,238 |
16,174 |
$3.39M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
5,535 |
5,084 |
$3.38M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
14,184 |
12,856 |
$2.77M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,205 |
3,990 |
$2.76M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
1,276 |
1,216 |
$2.65M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,103 |
2,884 |
$2.35M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
10,116 |
9,523 |
$2.10M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,176 |
8,815 |
$1.87M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
932 |
840 |
$1.82M |
| 92550 |
|
8,419 |
8,058 |
$1.76M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
8,746 |
3,500 |
$1.76M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,355 |
3,711 |
$1.62M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
11,324 |
5,277 |
$1.51M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,206 |
1,161 |
$1.49M |
| 94644 |
|
9,360 |
8,182 |
$1.30M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,855 |
2,689 |
$1.29M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,903 |
4,402 |
$1.26M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,002 |
2,827 |
$1.22M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,448 |
3,352 |
$1.18M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,956 |
6,017 |
$1.16M |
| 54161 |
|
416 |
403 |
$1.11M |
| 42830 |
|
347 |
338 |
$1.03M |
| 36430 |
|
1,677 |
1,225 |
$1.03M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,918 |
1,761 |
$998K |
| 0225U |
|
4,268 |
3,990 |
$964K |
| 94010 |
|
7,343 |
7,024 |
$939K |
| 76770 |
|
3,148 |
3,013 |
$845K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
31,496 |
29,572 |
$840K |
| 96112 |
|
848 |
811 |
$816K |
| 90791 |
Psychiatric diagnostic evaluation |
1,308 |
1,268 |
$774K |
| 95819 |
|
2,330 |
2,245 |
$770K |
| 12011 |
|
1,779 |
1,723 |
$716K |
| 93325 |
|
7,955 |
7,257 |
$699K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
47,883 |
43,547 |
$696K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,522 |
1,198 |
$687K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,501 |
4,169 |
$679K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,080 |
3,517 |
$663K |
| 96127 |
|
13,257 |
13,069 |
$651K |
| 12001 |
|
1,510 |
1,481 |
$625K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,068 |
1,963 |
$585K |
| 96040 |
|
3,607 |
3,443 |
$570K |
| 92523 |
|
2,042 |
1,927 |
$547K |
| 95782 |
|
461 |
447 |
$534K |
| 80053 |
Comprehensive metabolic panel |
39,097 |
32,437 |
$527K |
| 95951 |
|
559 |
505 |
$493K |
| 99381 |
|
2,291 |
2,139 |
$484K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,225 |
1,383 |
$477K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,595 |
1,541 |
$438K |
| 95816 |
|
1,037 |
1,013 |
$431K |
| 92579 |
|
5,703 |
5,477 |
$408K |
| 49452 |
|
715 |
640 |
$398K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
308 |
295 |
$391K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,266 |
1,181 |
$383K |
| 95715 |
|
492 |
445 |
$376K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
110 |
100 |
$375K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,598 |
1,505 |
$353K |
| 97161 |
|
1,462 |
1,377 |
$338K |
| 90651 |
|
1,100 |
1,068 |
$335K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,004 |
792 |
$334K |
| 16020 |
|
1,164 |
821 |
$332K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,106 |
773 |
$326K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,044 |
786 |
$321K |
| 76536 |
|
1,583 |
1,516 |
$313K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
11,757 |
11,213 |
$286K |
| 92587 |
|
4,991 |
4,779 |
$282K |
| 83655 |
|
17,566 |
17,057 |
$275K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12,016 |
11,486 |
$266K |
| 93976 |
|
1,703 |
1,619 |
$263K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
31,542 |
29,613 |
$258K |
| 94060 |
|
1,915 |
1,815 |
$240K |
| 10060 |
|
554 |
540 |
$238K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
201 |
169 |
$224K |
| 95700 |
|
1,299 |
1,219 |
$224K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
47,923 |
41,283 |
$223K |
| 99215 |
Prolong outpt/office vis |
680 |
673 |
$219K |
| 86922 |
|
2,486 |
1,980 |
$214K |
| 97802 |
|
1,262 |
1,203 |
$211K |
| 80061 |
Lipid panel |
21,762 |
20,893 |
$197K |
| 29075 |
|
500 |
480 |
$195K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
756 |
729 |
$192K |
| 96415 |
|
292 |
189 |
$189K |
| 92567 |
|
4,739 |
4,545 |
$188K |
| 76882 |
|
1,043 |
998 |
$178K |
| 93320 |
|
5,649 |
5,172 |
$173K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,945 |
2,717 |
$168K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
20,618 |
19,691 |
$165K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14,623 |
13,865 |
$165K |
| 71046 |
Radiologic examination, chest; 2 views |
14,009 |
12,906 |
$165K |
| 96138 |
|
357 |
333 |
$160K |
| 29125 |
|
532 |
511 |
$157K |
| 92557 |
|
1,928 |
1,842 |
$149K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
576 |
545 |
$143K |
| 12051 |
|
320 |
313 |
$141K |
| 96156 |
|
592 |
544 |
$138K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,552 |
7,531 |
$137K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
738 |
708 |
$136K |
| 87899 |
|
19,206 |
17,829 |
$134K |
| 86592 |
|
17,385 |
16,675 |
$133K |
| 87799 |
|
3,567 |
1,880 |
$130K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,953 |
16,399 |
$124K |
| G0379 |
Direct admission of patient for hospital observation care |
1,118 |
629 |
$124K |
| 99383 |
|
629 |
567 |
$121K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
398 |
322 |
$121K |
| 76775 |
|
576 |
558 |
$120K |
| 86703 |
|
21,878 |
20,778 |
$119K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
113 |
112 |
$117K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
67 |
41 |
$110K |
| 36415 |
Collection of venous blood by venipuncture |
44,338 |
37,828 |
$108K |
| 73590 |
|
3,999 |
3,555 |
$104K |
| 85018 |
|
19,794 |
19,208 |
$103K |
| 76825 |
|
1,239 |
1,135 |
$102K |
| 96130 |
|
151 |
140 |
$96K |
| 92555 |
|
3,686 |
3,552 |
$94K |
| 92552 |
|
2,305 |
2,231 |
$93K |
| 96160 |
|
1,935 |
1,912 |
$93K |
| 74018 |
|
2,905 |
2,609 |
$92K |
| 96139 |
|
258 |
246 |
$90K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
702 |
366 |
$89K |
| 97803 |
|
601 |
578 |
$85K |
| 0002A |
|
1,621 |
1,547 |
$85K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,250 |
10,601 |
$84K |
| J3490 |
Unclassified drugs |
79,787 |
58,629 |
$83K |
| 87497 |
|
2,558 |
1,487 |
$82K |
| 95712 |
|
190 |
183 |
$82K |
| 69210 |
|
1,040 |
996 |
$79K |
| 0001A |
|
1,629 |
1,560 |
$76K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
334 |
326 |
$76K |
| 87040 |
|
3,172 |
2,745 |
$74K |
| 82728 |
|
7,616 |
6,841 |
$72K |
| 72170 |
|
2,027 |
1,936 |
$72K |
| 96450 |
|
141 |
116 |
$71K |
| 76870 |
|
648 |
616 |
$70K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,791 |
1,649 |
$70K |
| 94645 |
|
1,897 |
1,728 |
$67K |
| 73630 |
|
4,746 |
4,431 |
$64K |
| 86480 |
|
2,542 |
2,444 |
$61K |
| 72081 |
|
1,610 |
1,558 |
$61K |
| 84439 |
|
6,368 |
5,999 |
$57K |
| 85007 |
|
12,771 |
9,598 |
$56K |
| 80197 |
|
3,318 |
1,842 |
$54K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,129 |
1,984 |
$52K |
| 73610 |
|
5,427 |
4,991 |
$52K |
| 72082 |
|
923 |
889 |
$52K |
| 92582 |
|
1,677 |
1,615 |
$52K |
| 70486 |
|
335 |
316 |
$50K |
| 73140 |
|
3,437 |
3,042 |
$49K |
| 82784 |
|
6,235 |
4,974 |
$49K |
| 83735 |
|
13,459 |
9,422 |
$47K |
| 64642 |
|
77 |
66 |
$47K |
| 76000 |
|
1,603 |
1,478 |
$47K |
| 77072 |
|
1,257 |
1,211 |
$46K |
| 93304 |
|
85 |
78 |
$44K |
| 85027 |
|
13,335 |
10,094 |
$44K |
| 92586 |
|
182 |
152 |
$43K |
| 73130 |
|
4,304 |
3,877 |
$42K |
| 83020 |
|
4,269 |
3,736 |
$42K |
| 73090 |
|
4,334 |
3,591 |
$42K |
| 80069 |
|
2,949 |
2,479 |
$42K |
| 76827 |
|
1,221 |
1,120 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,149 |
10,734 |
$41K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
106 |
101 |
$41K |
| 81001 |
|
19,857 |
17,893 |
$41K |
| 93225 |
|
1,368 |
1,295 |
$41K |
| 86850 |
|
4,951 |
3,826 |
$40K |
| 83970 |
|
1,378 |
1,277 |
$40K |
| 87536 |
|
1,154 |
1,110 |
$40K |
| 73100 |
|
1,660 |
1,420 |
$38K |
| 92553 |
|
563 |
542 |
$38K |
| 99384 |
|
205 |
190 |
$38K |
| 82664 |
|
1,043 |
881 |
$37K |
| 96367 |
|
824 |
656 |
$37K |
| 99382 |
|
167 |
153 |
$36K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
842 |
784 |
$34K |
| 81479 |
Unlisted molecular pathology procedure |
570 |
526 |
$34K |
| 92626 |
|
282 |
247 |
$34K |
| 87070 |
|
4,356 |
3,986 |
$34K |
| 73552 |
|
1,506 |
1,333 |
$33K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,624 |
1,496 |
$32K |
| 73080 |
|
2,591 |
2,151 |
$32K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
7,402 |
4,960 |
$32K |
| 74021 |
|
3,189 |
2,992 |
$32K |
| 0072A |
|
393 |
392 |
$32K |
| 0071A |
|
420 |
412 |
$31K |
| 73560 |
|
925 |
857 |
$31K |
| 92593 |
|
388 |
370 |
$30K |
| 86359 |
|
2,019 |
1,850 |
$30K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
586 |
501 |
$30K |
| 86900 |
|
5,019 |
3,883 |
$29K |
| 69200 |
|
331 |
315 |
$29K |
| 86945 |
|
1,772 |
1,288 |
$28K |
| 86140 |
|
7,226 |
6,643 |
$28K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,232 |
9,567 |
$28K |
| 73562 |
|
2,603 |
2,437 |
$27K |
| 11900 |
|
66 |
66 |
$27K |
| 96131 |
|
150 |
139 |
$27K |
| 86360 |
|
1,991 |
1,831 |
$27K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
52 |
46 |
$27K |
| J7799 |
Noc drugs, other than inhalation drugs, administered through dme |
3,197 |
2,712 |
$26K |
| 84100 |
|
12,827 |
9,128 |
$26K |
| 84460 |
|
9,761 |
9,384 |
$25K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
41 |
40 |
$25K |
| 95012 |
|
566 |
533 |
$25K |
| 93226 |
|
1,366 |
1,294 |
$25K |
| 92585 |
|
78 |
65 |
$25K |
| 85045 |
|
10,662 |
8,038 |
$25K |
| 90686 |
|
621 |
593 |
$24K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12,772 |
11,722 |
$23K |
| 87507 |
|
86 |
83 |
$23K |
| 97750 |
|
339 |
277 |
$23K |
| 73564 |
|
1,056 |
1,022 |
$23K |
| D1120 |
Prophylaxis - child |
502 |
500 |
$23K |
| 90620 |
|
395 |
383 |
$22K |
| 76885 |
|
95 |
89 |
$22K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
22,142 |
15,532 |
$22K |
| 83615 |
|
4,602 |
3,451 |
$21K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
659 |
614 |
$21K |
| 86834 |
|
199 |
191 |
$21K |
| 31575 |
|
184 |
178 |
$21K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,982 |
5,146 |
$20K |
| 82652 |
|
656 |
631 |
$20K |
| 92551 |
|
1,908 |
1,890 |
$19K |
| 82330 |
|
2,773 |
2,370 |
$19K |
| 87486 |
|
659 |
560 |
$19K |
| 86835 |
|
199 |
191 |
$19K |
| 88300 |
|
2,418 |
2,246 |
$18K |
| 83001 |
|
1,482 |
1,407 |
$18K |
| D0120 |
Periodic oral evaluation - established patient |
543 |
540 |
$18K |
| 82947 |
|
3,648 |
3,300 |
$18K |
| D1206 |
Topical application of fluoride varnish |
643 |
641 |
$18K |
| 36592 |
|
354 |
148 |
$18K |
| 83498 |
|
1,251 |
1,182 |
$18K |
| 85610 |
|
4,679 |
4,007 |
$18K |
| 96409 |
|
861 |
442 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,902 |
3,575 |
$17K |
| 82785 |
|
1,699 |
1,635 |
$17K |
| 85014 |
|
4,890 |
4,580 |
$17K |
| 86003 |
|
2,067 |
1,908 |
$17K |
| 83525 |
|
1,081 |
1,035 |
$16K |
| 82610 |
|
1,473 |
1,263 |
$16K |
| 87631 |
|
421 |
385 |
$16K |
| 80076 |
|
2,145 |
1,812 |
$16K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
2,292 |
2,139 |
$16K |
| 83516 |
|
1,865 |
1,739 |
$16K |
| 86901 |
|
5,011 |
3,879 |
$16K |
| 92060 |
|
706 |
686 |
$16K |
| 92592 |
|
175 |
167 |
$15K |
| 85651 |
|
6,702 |
6,161 |
$15K |
| 82570 |
|
3,544 |
3,234 |
$15K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,087 |
2,490 |
$15K |
| 92588 |
|
243 |
231 |
$15K |
| 82607 |
|
1,379 |
1,313 |
$15K |
| 86902 |
|
1,182 |
962 |
$15K |
| 84403 |
|
1,592 |
1,510 |
$14K |
| 87077 |
|
5,600 |
4,805 |
$14K |
| 81002 |
|
15,467 |
14,296 |
$14K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
566 |
560 |
$14K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,065 |
10,324 |
$14K |
| 90670 |
|
85 |
84 |
$14K |
| 81025 |
|
16,874 |
15,549 |
$13K |
| 93308 |
|
26 |
25 |
$13K |
| 73110 |
|
1,124 |
1,043 |
$13K |
| 97165 |
|
58 |
51 |
$13K |
| 84436 |
|
1,586 |
1,493 |
$13K |
| 94664 |
|
6,142 |
5,698 |
$13K |
| 73030 |
|
1,210 |
1,095 |
$13K |
| 70360 |
|
615 |
588 |
$12K |
| 83880 |
|
873 |
770 |
$12K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
4,240 |
4,059 |
$12K |
| 95117 |
|
291 |
204 |
$12K |
| 87205 |
|
12,037 |
11,180 |
$12K |
| 83540 |
|
3,645 |
3,454 |
$12K |
| 82465 |
|
2,745 |
2,444 |
$12K |
| 93321 |
|
448 |
406 |
$11K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,185 |
1,086 |
$11K |
| 80050 |
General health panel |
750 |
743 |
$11K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
5,982 |
5,337 |
$11K |
| 83002 |
|
1,419 |
1,353 |
$11K |
| 99070 |
|
1,047 |
857 |
$11K |
| 97162 |
|
66 |
61 |
$11K |
| 83550 |
|
3,191 |
3,028 |
$10K |
| 51728 |
|
28 |
25 |
$10K |
| 92504 |
|
196 |
189 |
$10K |
| 29065 |
|
35 |
33 |
$10K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
4,402 |
4,066 |
$10K |
| 86828 |
|
207 |
193 |
$10K |
| 97763 |
|
143 |
72 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,081 |
3,714 |
$10K |
| 73521 |
|
345 |
332 |
$10K |
| 70544 |
|
26 |
25 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
1,135 |
1,020 |
$9K |
| 73070 |
|
470 |
398 |
$9K |
| 24640 |
|
14 |
14 |
$9K |
| 84702 |
|
1,355 |
1,241 |
$8K |
| 82248 |
|
3,316 |
2,430 |
$8K |
| 77080 |
|
96 |
95 |
$8K |
| 87101 |
|
923 |
896 |
$8K |
| 89050 |
|
831 |
658 |
$8K |
| 84450 |
|
3,505 |
3,348 |
$8K |
| 88185 |
|
122 |
97 |
$8K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
266 |
234 |
$8K |
| 73000 |
|
389 |
364 |
$8K |
| 87581 |
|
628 |
533 |
$8K |
| 86355 |
|
570 |
506 |
$8K |
| A0434 |
Specialty care transport (sct) |
467 |
399 |
$8K |
| 82150 |
|
1,966 |
1,778 |
$8K |
| 83605 |
|
2,479 |
2,193 |
$7K |
| 85730 |
|
4,078 |
3,654 |
$7K |
| 84402 |
|
914 |
878 |
$7K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
6,689 |
5,940 |
$7K |
| 99000 |
|
3,290 |
3,059 |
$7K |
| 97760 |
|
54 |
49 |
$7K |
| A0425 |
Ground mileage, per statute mile |
3,935 |
3,600 |
$7K |
| 82948 |
|
3,986 |
3,402 |
$7K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
7,232 |
6,657 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,885 |
5,904 |
$7K |
| 82977 |
|
2,314 |
2,000 |
$7K |
| 73060 |
|
709 |
604 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,455 |
6,590 |
$6K |
| 87535 |
|
162 |
150 |
$6K |
| 86803 |
|
637 |
601 |
$6K |
| 84305 |
|
623 |
603 |
$6K |
| 92652 |
|
74 |
65 |
$6K |
| 82139 |
|
473 |
399 |
$6K |
| 31526 |
|
13 |
12 |
$6K |
| 87186 |
|
4,906 |
4,592 |
$6K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,527 |
4,139 |
$6K |
| J7642 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
336 |
307 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,475 |
2,806 |
$5K |
| 12002 |
|
13 |
12 |
$5K |
| 73660 |
|
472 |
440 |
$5K |
| 87529 |
|
335 |
323 |
$5K |
| 93886 |
|
17 |
16 |
$5K |
| 86357 |
|
556 |
497 |
$5K |
| 83690 |
|
4,045 |
3,686 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,618 |
5,714 |
$5K |
| 92610 |
|
12 |
12 |
$5K |
| 90619 |
|
22 |
22 |
$5K |
| 88304 |
|
468 |
430 |
$5K |
| 86364 |
|
926 |
900 |
$5K |
| 17250 |
|
13 |
13 |
$5K |
| 82525 |
|
288 |
267 |
$5K |
| J3535 |
Drug administered through a metered dose inhaler |
8,020 |
7,020 |
$5K |
| 82803 |
|
1,978 |
1,737 |
$5K |
| 51784 |
|
43 |
40 |
$4K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
10,660 |
9,382 |
$4K |
| 82247 |
|
1,253 |
930 |
$4K |
| C1889 |
Implantable/insertable device, not otherwise classified |
920 |
870 |
$4K |
| 84146 |
|
480 |
452 |
$4K |
| 87340 |
|
988 |
925 |
$4K |
| 84550 |
|
2,009 |
1,720 |
$4K |
| 11981 |
|
13 |
12 |
$4K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
983 |
901 |
$4K |
| 82550 |
|
1,694 |
1,507 |
$4K |
| J9370 |
Vincristine sulfate, 1 mg |
435 |
177 |
$4K |
| 83520 |
|
687 |
639 |
$4K |
| 92595 |
|
133 |
127 |
$4K |
| 82657 |
|
657 |
587 |
$4K |
| 86160 |
|
692 |
544 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,522 |
1,394 |
$3K |
| 85660 |
|
1,145 |
967 |
$3K |
| 72156 |
|
13 |
13 |
$3K |
| 82670 |
|
355 |
342 |
$3K |
| 90715 |
|
579 |
551 |
$3K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
37 |
37 |
$3K |
| 84480 |
|
857 |
811 |
$3K |
| 82043 |
|
1,182 |
1,129 |
$3K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
380 |
345 |
$3K |
| 86706 |
|
697 |
654 |
$3K |
| 87088 |
|
5,473 |
5,127 |
$3K |
| 88184 |
|
111 |
98 |
$3K |
| 82565 |
|
795 |
750 |
$3K |
| 92133 |
|
124 |
122 |
$3K |
| 84630 |
|
336 |
318 |
$3K |
| 83789 |
|
545 |
500 |
$3K |
| 87045 |
|
248 |
234 |
$3K |
| 90685 |
|
99 |
85 |
$2K |
| 89051 |
|
926 |
739 |
$2K |
| 82627 |
|
236 |
228 |
$2K |
| 82747 |
|
323 |
313 |
$2K |
| C1769 |
Guide wire |
900 |
841 |
$2K |
| 0352U |
|
229 |
225 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
727 |
553 |
$2K |
| 80329 |
|
93 |
85 |
$2K |
| 74240 |
|
14 |
12 |
$2K |
| 36591 |
|
89 |
63 |
$2K |
| 84155 |
|
954 |
834 |
$2K |
| 84478 |
|
1,453 |
1,182 |
$2K |
| 92650 |
|
44 |
39 |
$2K |
| 86038 |
|
402 |
378 |
$2K |
| 80047 |
|
129 |
103 |
$2K |
| D7140 |
Extraction, erupted tooth or exposed root |
21 |
14 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
895 |
864 |
$2K |
| 84156 |
|
1,234 |
1,113 |
$2K |
| 90688 |
|
42 |
41 |
$2K |
| A4649 |
Surgical supply; miscellaneous |
310 |
298 |
$2K |
| 84134 |
|
200 |
190 |
$2K |
| 94729 |
|
65 |
63 |
$2K |
| 81229 |
|
19 |
18 |
$2K |
| 92556 |
|
123 |
118 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,839 |
1,626 |
$1K |
| 73600 |
|
66 |
58 |
$1K |
| 80320 |
|
104 |
94 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,072 |
734 |
$1K |
| 80164 |
|
63 |
56 |
$1K |
| 72100 |
|
95 |
94 |
$1K |
| 85379 |
|
186 |
166 |
$1K |
| 83993 |
|
126 |
116 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
522 |
203 |
$1K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
101 |
90 |
$1K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
2,254 |
2,080 |
$1K |
| 84295 |
|
1,843 |
1,613 |
$1K |
| 82261 |
|
209 |
194 |
$1K |
| 86701 |
|
181 |
170 |
$1K |
| V5011 |
Fitting/orientation/checking of hearing aid |
26 |
26 |
$1K |
| 86769 |
|
246 |
232 |
$1K |
| 74230 |
|
12 |
12 |
$1K |
| 82533 |
|
84 |
75 |
$1K |
| 92511 |
|
14 |
13 |
$999.78 |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
14 |
14 |
$996.35 |
| 94726 |
|
12 |
12 |
$944.88 |
| G9019 |
Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) |
491 |
409 |
$941.38 |
| 74019 |
|
143 |
126 |
$937.54 |
| 84484 |
|
656 |
586 |
$912.46 |
| 82726 |
|
292 |
271 |
$897.73 |
| 82552 |
|
178 |
155 |
$888.48 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
609 |
566 |
$841.41 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
3,354 |
3,143 |
$841.31 |
| 85240 |
|
130 |
126 |
$834.28 |
| 82960 |
|
304 |
282 |
$826.34 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,300 |
1,127 |
$825.77 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
14,619 |
11,485 |
$808.49 |
| 84446 |
|
203 |
199 |
$805.56 |
| 83721 |
|
55 |
54 |
$788.22 |
| 97164 |
|
16 |
12 |
$780.54 |
| 90656 |
|
89 |
89 |
$742.72 |
| D0140 |
Limited oral evaluation - problem focused |
18 |
18 |
$722.65 |
| 84255 |
|
141 |
139 |
$706.36 |
| 92604 |
|
25 |
24 |
$680.09 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
67 |
64 |
$635.04 |
| 84590 |
|
172 |
170 |
$618.38 |
| 81003 |
|
5,350 |
5,082 |
$600.07 |
| J1644 |
Injection, heparin sodium, per 1000 units |
474 |
142 |
$592.07 |
| 84520 |
|
605 |
578 |
$588.93 |
| 99292 |
|
183 |
180 |
$572.95 |
| J2704 |
Injection, propofol, 10 mg |
7,295 |
6,723 |
$562.14 |
| 86376 |
|
25 |
24 |
$559.98 |
| D9230 |
Inhalation of nitrous oxide / analgesia, anxiolysis |
12 |
12 |
$552.00 |
| 86702 |
|
181 |
170 |
$537.28 |
| 84132 |
|
1,937 |
1,729 |
$516.54 |
| 84300 |
|
418 |
354 |
$506.09 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
56 |
37 |
$505.09 |
| 73502 |
|
27 |
26 |
$496.72 |
| D0272 |
Bitewings - two radiographic images |
16 |
16 |
$495.80 |
| 87102 |
|
125 |
119 |
$465.50 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
622 |
583 |
$465.25 |
| 87181 |
|
119 |
111 |
$432.13 |
| 72070 |
|
13 |
12 |
$413.86 |
| 86808 |
|
12 |
12 |
$411.93 |
| 85520 |
|
15 |
12 |
$399.96 |
| 96376 |
|
738 |
568 |
$396.71 |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
14 |
13 |
$393.50 |
| 82776 |
|
195 |
181 |
$373.00 |
| 82760 |
|
195 |
181 |
$373.00 |
| 90734 |
|
71 |
71 |
$366.88 |
| 85246 |
|
74 |
73 |
$358.26 |
| 82272 |
|
112 |
103 |
$349.14 |
| 86704 |
|
96 |
89 |
$328.94 |
| 86747 |
|
14 |
13 |
$326.10 |
| 87046 |
|
161 |
149 |
$324.91 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
39 |
24 |
$314.81 |
| 73120 |
|
28 |
27 |
$304.78 |
| 86008 |
|
78 |
77 |
$304.76 |
| 85384 |
|
192 |
175 |
$302.41 |
| 82379 |
|
61 |
57 |
$297.72 |
| 81005 |
|
318 |
276 |
$271.38 |
| 80183 |
|
12 |
12 |
$248.94 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
118 |
100 |
$243.09 |
| 92594 |
|
13 |
13 |
$239.45 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
61 |
60 |
$234.66 |
| J7699 |
Noc drugs, inhalation solution administered through dme |
687 |
615 |
$234.40 |
| 86225 |
|
75 |
66 |
$228.82 |
| D0220 |
Intraoral - periapical first radiographic image |
13 |
13 |
$210.44 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
155 |
141 |
$210.04 |
| 81015 |
|
3,769 |
3,573 |
$188.20 |
| 82805 |
|
189 |
176 |
$175.70 |
| 82105 |
|
14 |
14 |
$173.26 |
| 82542 |
|
25 |
25 |
$170.97 |
| J7510 |
Prednisolone oral, per 5 mg |
299 |
267 |
$153.33 |
| 86665 |
|
16 |
16 |
$141.33 |
| 51797 |
|
28 |
25 |
$90.81 |
| 87808 |
|
684 |
641 |
$90.23 |
| 77075 |
|
12 |
12 |
$87.08 |
| 84481 |
|
15 |
14 |
$77.78 |
| 85245 |
|
27 |
25 |
$69.94 |
| 86308 |
|
51 |
50 |
$68.03 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
7,160 |
6,665 |
$65.89 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
29 |
24 |
$65.62 |
| 86317 |
|
27 |
26 |
$64.67 |
| J0200 |
Injection, alatrofloxacin mesylate, 100 mg |
545 |
535 |
$37.62 |
| 86141 |
|
127 |
113 |
$32.57 |
| 92015 |
Determination of refractive state |
2,611 |
2,533 |
$30.00 |
| L8699 |
Prosthetic implant, not otherwise specified |
631 |
616 |
$29.10 |
| 80143 |
|
143 |
132 |
$27.15 |
| 90713 |
|
45 |
44 |
$22.00 |
| 80179 |
|
127 |
117 |
$15.95 |
| 86756 |
|
12 |
12 |
$14.51 |
| 88720 |
|
28 |
25 |
$14.00 |
| 82077 |
|
169 |
161 |
$13.91 |
| 87147 |
|
13 |
13 |
$12.66 |
| 87177 |
|
13 |
13 |
$12.01 |
| 76010 |
|
189 |
176 |
$10.00 |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
65 |
59 |
$9.28 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
354 |
305 |
$3.53 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
65 |
36 |
$1.44 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
26 |
12 |
$1.08 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
61 |
42 |
$0.27 |
| 0250 |
|
2,604 |
2,482 |
$0.00 |
| 96368 |
|
48 |
48 |
$0.00 |
| 0710 |
|
157 |
155 |
$0.00 |
| 90680 |
|
32 |
32 |
$0.00 |
| 90744 |
|
114 |
114 |
$0.00 |
| 29130 |
|
15 |
12 |
$0.00 |
| 0270 |
|
38 |
38 |
$0.00 |
| 0370 |
|
110 |
109 |
$0.00 |
| 72157 |
|
12 |
12 |
$0.00 |
| 90716 |
|
23 |
23 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
25 |
25 |
$0.00 |
| V5264 |
Ear mold/insert, not disposable, any type |
29 |
26 |
$0.00 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
26 |
25 |
$0.00 |
| 96168 |
|
15 |
14 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
15 |
14 |
$0.00 |
| 90698 |
|
37 |
34 |
$0.00 |
| V5275 |
Ear impression, each |
12 |
12 |
$0.00 |
| 80358 |
|
13 |
13 |
$0.00 |
| 94200 |
|
12 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
620 |
594 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
143 |
138 |
$0.00 |
| 84145 |
|
29 |
27 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
84 |
79 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
45 |
33 |
$0.00 |
| 0272 |
|
83 |
81 |
$0.00 |
| 69209 |
|
40 |
39 |
$0.00 |
| 90710 |
|
37 |
36 |
$0.00 |
| 0451 |
|
809 |
717 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
39 |
37 |
$0.00 |
| 82375 |
|
23 |
13 |
$0.00 |
| 71048 |
|
26 |
26 |
$0.00 |
| 93356 |
|
16 |
12 |
$0.00 |
| A6211 |
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing |
13 |
12 |
$0.00 |
| 96167 |
|
66 |
62 |
$0.00 |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
14 |
14 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
14 |
14 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
29 |
13 |
$0.00 |
| 90707 |
|
22 |
22 |
$0.00 |